NLSP: NLS Pharmaceutics AG Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 6.51
Enterprise Value ($M) 7.67
Book Value ($M) -9.27
Book Value / Share -4.88
Price / Book -0.70
NCAV ($M) -9.27
NCAV / Share -4.89
Price / NCAV -0.70

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.15
Current Ratio 0.15

Balance Sheet (mrq) ($M)
Current Assets 1.19
Assets 1.19
Liabilities 10.46
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
7 days ago 13G/A Hafner Ronald 8.10
11-14 13G/A Lind Global Fund II LP 8.10 -97.59
11-14 13G Armistice Capital, Llc 9.99
11-04 13G/A YA II PN, Ltd. -100.00
11-04 13G/A Grisard Felix 2.80 -96.69
10-15 13G Alpha Capital Anstalt 9.99

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-27 57,516 123,698 46.50
2024-11-26 1,201 22,680 5.30
2024-11-25 5,911 47,110 12.55
2024-11-22 5,310 64,371 8.25

(click for more detail)

Similar Companies
NATR – Nature's Sunshine Products, Inc. NERV – Minerva Neurosciences, Inc.
NKTR – Nektar Therapeutics NRBO – NeuroBo Pharmaceuticals, Inc.
NRSN – NeuroSense Therapeutics Ltd.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.